Published on: February 3, 2022
Random and illustrative stories about the global pandemic and how businesses and various business sectors are trying to recover from it, with brief, occasional, italicized and sometimes gratuitous commentary…
• The United States now has had a total of 76,882,290 cases of Covid-19 coronavirus, resulting in 917,600 deaths and 47,112,620 reported recoveries.
Globally, there have been 385,910,363 total cases, with 5,721,140 resultant fatalities and 305,793,041 reported recoveries. (Source.)
• The Centers for Disease Control and Prevention (CDC) says that 75.4 percent of the total US population has received at least one dose of vaccine … 63.9 percent is fully vaccinated … and 41.8 percent has received a vaccine booster shot. The CDC also says that 50.6 percent of the total US population is eligible for a vaccine booster shot but has not received one.
• The New York Times reports that the next big thing in Covid-19 vaccines may not be shots, but a nasal spray.
"Currently available vaccines produce powerful, long-lasting immunity against severe illness, as several studies have recently shown," the Times writes. "But their protection against infection from the coronavirus is transient, and can falter as new variants of the virus emerge — a failing that has prompted talk of regular booster shots.
"Nasal vaccines may be the best way to prevent infections long term, because they provide protection exactly where it is needed to fend off the virus: the mucosal linings of the airways, where the coronavirus first lands … Immunizing entire populations with a nasal or oral vaccine would be faster in the middle of a surge than injections, which require skill and time to administer. A nasal vaccine is likely to be more palatable to many (including children) than painful shots, and would circumvent shortages of needles, syringes and other materials."
The Times says that India-based "Bharat Biotech is among the world’s leading vaccine manufacturers. Its best known product, Covaxin, is authorized to prevent Covid in India and many other countries. But its experimental nasal vaccine may prove to be the real game changer."